BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37932117)

  • 1. Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice.
    Międzybrodzki R; Kasprzak H; Letkiewicz S; Rogóż P; Żaczek M; Thomas J; Górski A
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S395-S400. PubMed ID: 37932117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological limitations of phage therapy.
    Nilsson AS
    Ups J Med Sci; 2019 Nov; 124(4):218-227. PubMed ID: 31724901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological foundations of successful bacteriophage therapy.
    Venturini C; Petrovic Fabijan A; Fajardo Lubian A; Barbirz S; Iredell J
    EMBO Mol Med; 2022 Jul; 14(7):e12435. PubMed ID: 35620963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.
    Abdelkader K; Gerstmans H; Saafan A; Dishisha T; Briers Y
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phage therapy: a realistic weapon against multidrug resistant bacteria].
    Dufour N; Debarbieux L
    Med Sci (Paris); 2017 Apr; 33(4):410-416. PubMed ID: 28497737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation.
    Nang SC; Lin YW; Petrovic Fabijan A; Chang RYK; Rao GG; Iredell J; Chan HK; Li J
    Clin Microbiol Infect; 2023 Jun; 29(6):702-709. PubMed ID: 36736661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phages Needed against Resistant Bacteria.
    Moelling K
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy.
    Segall AM; Roach DR; Strathdee SA
    Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review.
    Lin J; Du F; Long M; Li P
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
    Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
    Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications.
    Esteves NC; Scharf BE
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriophage Therapy of Urological Infections].
    Perepanova TS; Merinov DS; Kazachenko AV; Khazan PL; Malova YA
    Urologiia; 2020 Nov; (5):106-114. PubMed ID: 33185357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.